Abstract book 2011 - ISHAM

* Pr. Raymond Robert (Groupe d'Etude des Interactions Hôte-Pathogène, UPRES-EA 3142,Institut de Biologie en Santé-IRIS, CHU, 4 rue Larrey, 49933 Angers cedex 9, France. Phone:33-(0)2-41 22 66 62; Fax: 33-(0)2-41 48 67 33; E-mail: Raymond.Robert@univ-angers.fr) –Biological diagnosis.* Amandine Rougeron (Groupe d'Etude des Interactions Hôte-Pathogène, UPRES-EA 3142,Institut de Biologie en Santé-IRIS, CHU, 4 rue Larrey, 49933 Angers cedex 9, France. Phone:33-(0)2-44 68 83 64; Fax: 33-(0)2-44 68 83 69; E-mail: amandine.rougeron@gmail.com) –Epidemiological studies, ecology.* Dr. Carsten Schwarz (Leitung Erwachsenen-Mukoviszidose, Endoskopie undLungentransplantation Oberarzt Christiane Herzog Zentrum/Mukoviszidose Charité -Universitätsmedizin Berlin Klinik für Pädiatrie m. S. Pneumologie und Immunologie,Augustenburger Platz 1, 13353 Berlin, Germany. Phone: 49-(0)30-450 666 576; Fax: 49-(0)30-450 566 959; E-mail: carsten.schwarz@charite.de) – Clinical surveillance.* Dr. David Shoseyov (Cystic Fibrosis Center, Paediatrics Department, Hadassah-HebrewUniversity medical center, Mt Scopus, POB 24035, 91240 Jerusalem, Israel. Phone: 972-507874091; Fax: 972-2-5844427; E-mail: shoseyov@hadassah.org.il) – Clinical surveillance.* Dr. Maria Simitsopoulou (Aristotle University of Thessaloniki, Laboratory of InfectiousDiseases, 3rd Department of Pediatrics, Hippokration Hospital, 49 Konstantinoupoleos street,54642 Thessaloniki, Greece. Phone: 30-2310-892447; Fax: 30-2310-992981; E-mail:simitsop2@yahoo.com) – Biological diagnosis, physiopathology.* Dr. Francoise Symoens (Scientific Institute of Public Health, Mycology-aerobiology Section,14 rue Juliette Wytsmans, 1050 Brussels, Belgium. Phone: 32-2-642 56 30; Fax: 32-2-642 5519; E-mail: francoise.symoens@wiv-isp.be) – Preservation of clinical and environmentalisolates, epidemiological studies.* Dr. Paul Terpstra (Canisius Wilhelmina Hospital/University Medical Centre St Radboud,Afdeling Medische Microbiologie, Weg door Jonkerbos 100, 6532 SZ Nijmegen, TheNetherlands. Phone: 31-24-365 7515; E-mail: pauldterpstra@gmail.com) – Clinicalsurveillance, epidemiological studies.* Dr. Christopher Thornton (Hybridoma Laboratory, School of Biosciences, Geoffrey PopeBuilding, University of Exeter, Stocker Road, Exeter, Devon, EX4 4QD, United Kingdom.Phone: 44 (0)1392 725172; Fax: 44 (0)1392 263434; E-mail: C.R.Thornton@ex.ac.uk) –Production of Hybridoma, Environmental studies.* Dr. Marie-Laure Uffredi (Service de Pneumologie, Centre Hospitalier de BretagneAtlantique, 56017 Vannes cedex, France. Phone: 33-(0)2 97 01 48 86; Fax: 33-(0)2-97 01 9947; E-mail: marie-laure.uffredi@ch-bretagne-atlantique.fr) – Clinical surveillance.* Dr. Annabelle Varrot (Centre de Recherche sur les Macromolécules végétales (CERMAV),UPR-CNRS 5301, BP 53, 38041 Grenoble Cedex 9, France. Phone: 33-(0)4-76 03 76 34; Fax:33-(0)4-76 54 72 03; E-mail: varrot@cermav.cnrs.fr) – Physiopathology.* Dr. Jan-Bart Yntema (Department of Pediatric Pulmonology, Radboud University NijmegenMedical Center, P.O. Box 9101 # 833, 6500 HB Nijmegen, The Netherlands. Phone : 31-24-361 9118; Fax: 31-24-366 8532; E-mail: j.yntema@cukz.umcn.nl) – Clinical surveillance.* Dr. Rachid Zouhair (Département de Biologie, Faculté des Sciences, Université de Meknès,Meknès, Morocco. Phone : 212-670-88 59 60; E-mail: zouhair_rachid@hotmail.com) –Epidemiological studies.